Daniel Grosslight

Q: What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of 93.26294184221162.

Q: What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of 9.722610637121804.

Citigroup | Healthcare

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector. Ranked #1111 out of 4570 analysts, they have issued 33 stock ratings with a success rate of 93.26% and an average return of 9.72%.

Daniel Grosslight has a well-established track record, with 33 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.26% and an average return of 9.72%, underscoring their expertise and ability to identify winning opportunities for investors.

#1111

Out of 4570

Total Ratings

+93.26%

Success Rate

+9.72%

Average Return

Recent Ratings Analysis

HIMS

Hold

Mar 10, 2026

Target

$24.00

Current

$22.16

Performance

Daniel Grosslight rated HIMS as Neutral on Mar 10, 2026, setting a price target of 24. The Hold stance appears justified, as shares hovered around 22.16 with a % move.

TDOC

Hold

Mar 03, 2026

Target

$9.00

Current

$5.30

Performance

3.92%

On Mar 03, 2026, TDOC was given a Neutral rating by Daniel Grosslight, with a target price of 9. Market indecision, reflected in sideways trading near 5.3, supported the cautious call.

PRVA

Buy

Mar 03, 2026

Target

$34.00

Current

$23.30

Performance

-1.98%

PRVA received a Buy rating from Daniel Grosslight on Mar 03, 2026, aiming for 34. Price action was muted, as shares hovered around 23.3 despite the bullish outlook.

GDRX

Buy

Mar 03, 2026

Target

$4.50

Current

$2.35

Performance

13.53%

On Mar 03, 2026, Daniel Grosslight published a Buy outlook on GDRX, with a target of 4.5. Shares gained 13.53%, underscoring the accuracy of the bullish outlook toward 4.5.

AGL

Hold

Mar 03, 2026

Target

$0.85

Current

$0.60

Performance

5.73%

Daniel Grosslight on Mar 03, 2026 assigned AGL a Neutral rating, with a price target of 0.85. Shares outperformed expectations, climbing 5.73% despite the neutral view.

EVH

Buy

Feb 26, 2026

Target

$6.00

Current

$3.04

Performance

-8.43%

On Feb 26, 2026, Daniel Grosslight reaffirmed EVH with a Buy rating, targeting 6. Shares slid 8.43% despite the recommendation, highlighting downside risks.

CTEV

Buy

Feb 25, 2026

Target

$63.00

Current

$16.77

Performance

13.16%

CTEV was rated Buy by Daniel Grosslight on Feb 25, 2026, with a price objective of 63. A bullish response from the market helped close the gap of 46.23 to the target.

WAY

Buy

Feb 18, 2026

Target

$46.00

Current

$25.88

Performance

1.85%

On Feb 18, 2026, Daniel Grosslight initiated coverage on WAY with a Buy rating and target of 46. Neutral price movement of 1.85% leaves room for interpretation.

PHR

Buy

Jan 09, 2026

Target

$29.00

Current

$12.06

Performance

-30.01%

Daniel Grosslight issued a Buy recommendation for PHR on Jan 09, 2026, price target set at 29. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

HCAT

Hold

Jan 09, 2026

Target

$3.25

Current

$1.91

Performance

-22.67%

On Jan 09, 2026, HCAT was evaluated by Daniel Grosslight, who gave a Neutral rating and target of 3.25. The Hold call avoided chasing into subsequent weakness of 22.67%.

CAH

Buy

Jan 09, 2026

Target

$244.00

Current

$222.28

Performance

10.53%

Daniel Grosslight rated CAH as Buy on Jan 09, 2026, setting a price target of 244. The call has proven timely, with shares rising 10.53% toward the price target of 244.

MCK

Buy

Sep 24, 2025

Target

$860.00

Current

$942.16

Performance

23.87%

On Sep 24, 2025, MCK was given a Buy rating by Daniel Grosslight, with a target price of 860. The stock rallied 23.87% after the rating, narrowing the gap to the target of 860 and validating the bullish stance.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.68

Performance

-51.01%

OMI received a Buy rating from Daniel Grosslight on Aug 12, 2025, aiming for 7. The rating hasn’t played out as hoped, with the stock trading 51.01% below expectations.

MPLN

Hold

Jan 10, 2025

Target

$12.50

Current

$23.15

Performance

81.85%

On Jan 10, 2025, Daniel Grosslight published a Neutral outlook on MPLN, with a target of 12.5. The Hold call missed some of the bullish momentum as shares advanced toward 12.5.

Frequency Asked Questions

Who is Daniel Grosslight?

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector.

What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of +93.26%.

How many ratings has Daniel Grosslight issued?

Daniel Grosslight has issued 33 stock ratings so far.

What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of +9.72%.

What is Daniel Grosslight's ranking?

Daniel Grosslight is ranked #1111 out of 4570 analysts.

What types of ratings does Daniel Grosslight give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Daniel Grosslight?

You can follow Daniel Grosslight by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Daniel Grosslight?

Their latest rating was a Hold on HIMS issued on 2026-03-10.